These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 30539587)
21. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis. Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338 [TBL] [Abstract][Full Text] [Related]
22. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893 [TBL] [Abstract][Full Text] [Related]
23. Complement components and their autoantibodies. Norsworthy P; Davies KA Mol Biotechnol; 2003 Mar; 23(3):259-70. PubMed ID: 12665695 [TBL] [Abstract][Full Text] [Related]
24. Detection of serum antibodies to S-antigen by surface plasmon resonance (SPR). Kurowska E; Szymiczek M; Gorczyca WA; Kuropatwa M J Immunoassay Immunochem; 2006; 27(4):331-40. PubMed ID: 16981646 [TBL] [Abstract][Full Text] [Related]
25. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus. Daha MR; Hazevoet HM; Vanes LA Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604 [TBL] [Abstract][Full Text] [Related]
26. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro. Pang Y; Yang XW; Song Y; Yu F; Zhao MH Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568 [TBL] [Abstract][Full Text] [Related]
27. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328 [TBL] [Abstract][Full Text] [Related]
28. Anti-C1q autoantibodies in murine lupus nephritis. Trouw LA; Seelen MA; Visseren R; Duijs JM; Benediktsson H; de Heer E; Roos A; van Kooten C; Daha MR Clin Exp Immunol; 2004 Jan; 135(1):41-8. PubMed ID: 14678263 [TBL] [Abstract][Full Text] [Related]
29. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome. Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055 [TBL] [Abstract][Full Text] [Related]
30. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor. Ito S; Tamura N; Fujita T Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642 [TBL] [Abstract][Full Text] [Related]
34. Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome. Blanc C; Roumenina LT; Ashraf Y; Hyvärinen S; Sethi SK; Ranchin B; Niaudet P; Loirat C; Gulati A; Bagga A; Fridman WH; Sautès-Fridman C; Jokiranta TS; Frémeaux-Bacchi V; Dragon-Durey MA J Immunol; 2012 Oct; 189(7):3528-37. PubMed ID: 22922817 [TBL] [Abstract][Full Text] [Related]
35. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways. Thanei S; Vanhecke D; Trendelenburg M Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903 [TBL] [Abstract][Full Text] [Related]
36. Complement Dysregulation and Disease: Insights from Contemporary Genetics. Liszewski MK; Java A; Schramm EC; Atkinson JP Annu Rev Pathol; 2017 Jan; 12():25-52. PubMed ID: 27959629 [TBL] [Abstract][Full Text] [Related]